GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Recommendation of “Hold” by Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have received an average rating of “Hold” from the fourteen research firms that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have given a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $92.1667.

A number of research firms recently commented on GEHC. Bank of America increased their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Barclays lifted their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Finally, Stifel Nicolaus upped their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th.

Hedge Funds Weigh In On GE HealthCare Technologies

Hedge funds have recently modified their holdings of the business. Wedge Capital Management L L P NC acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at about $26,859,000. Temasek Holdings Private Ltd purchased a new stake in GE HealthCare Technologies during the 3rd quarter valued at approximately $99,922,000. Valicenti Advisory Services Inc. lifted its position in GE HealthCare Technologies by 22.6% during the 3rd quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after acquiring an additional 12,550 shares during the period. Locust Wood Capital Advisers LLC grew its stake in shares of GE HealthCare Technologies by 7.1% in the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after purchasing an additional 137,992 shares during the last quarter. Finally, Nan Fung Trinity HK Ltd. purchased a new position in shares of GE HealthCare Technologies in the 3rd quarter valued at approximately $23,206,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 2.3%

GEHC opened at $70.35 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $89.77. The company has a market cap of $32.10 billion, a P/E ratio of 15.43, a PEG ratio of 1.58 and a beta of 1.17. The business’s 50-day simple moving average is $77.08 and its 200-day simple moving average is $78.08.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. During the same period in the prior year, the company posted $1.45 earnings per share. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.